Your browser doesn't support javascript.
loading
Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.
Schaefer, Robin; Schmidt, Heather-Marie A; Ravasi, Giovanni; Mozalevskis, Antons; Rewari, Bharat B; Lule, Frank; Yeboue, Kouadio; Brink, Anne; Mangadan Konath, Nabeel; Sharma, Mukta; Seguy, Nicole; Hermez, Joumana; Alaama, Ahmed S; Ishikawa, Naoko; Dongmo Nguimfack, Boniface; Low-Beer, Daniel; Baggaley, Rachel; Dalal, Shona.
Afiliación
  • Schaefer R; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland. Electronic address: schaeferr@who.int.
  • Schmidt HA; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland; UNAIDS Regional Office for Asia and the Pacific, Bangkok, Thailand.
  • Ravasi G; Pan-American Health Organization, Washington, DC, USA.
  • Mozalevskis A; World Health Organization Regional Office for Europe, Copenhagen, Denmark.
  • Rewari BB; World Health Organization Regional Office for South-East Asia, New Delhi, India.
  • Lule F; World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo.
  • Yeboue K; World Health Organization Regional Office for Africa, Inter-Country Support Team, Ouagadougou, Burkina Faso.
  • Brink A; World Health Organization Regional Office for the Western Pacific, Manila, Philippines.
  • Mangadan Konath N; World Health Organization Regional Office for South-East Asia, New Delhi, India.
  • Sharma M; World Health Organization Regional Office for South-East Asia, New Delhi, India.
  • Seguy N; World Health Organization Regional Office for Europe, Copenhagen, Denmark.
  • Hermez J; World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
  • Alaama AS; World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
  • Ishikawa N; World Health Organization Regional Office for the Western Pacific, Manila, Philippines.
  • Dongmo Nguimfack B; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
  • Low-Beer D; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
  • Baggaley R; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
  • Dalal S; Global HIV, Hepatitis and STIs Programmes, World Health Organization, Geneva, Switzerland.
Lancet HIV ; 8(8): e502-e510, 2021 08.
Article en En | MEDLINE | ID: mdl-34265283
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 10_ODS3_salud_sexual_reprodutiva / 2_ODS3 / 4_TD Problema de salud: 10_sexually_transmitted_infections / 2_cobertura_universal / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Infecciones por VIH / Salud Global / Guías de Práctica Clínica como Asunto / Profilaxis Pre-Exposición / SARS-CoV-2 / COVID-19 Tipo de estudio: Guideline Límite: Female / Humans / Male Idioma: En Revista: Lancet HIV Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 10_ODS3_salud_sexual_reprodutiva / 2_ODS3 / 4_TD Problema de salud: 10_sexually_transmitted_infections / 2_cobertura_universal / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Infecciones por VIH / Salud Global / Guías de Práctica Clínica como Asunto / Profilaxis Pre-Exposición / SARS-CoV-2 / COVID-19 Tipo de estudio: Guideline Límite: Female / Humans / Male Idioma: En Revista: Lancet HIV Año: 2021 Tipo del documento: Article